U.S. markets closed
  • S&P Futures

    4,284.75
    -1.75 (-0.04%)
     
  • Dow Futures

    33,976.00
    -5.00 (-0.01%)
     
  • Nasdaq Futures

    13,522.00
    -1.25 (-0.01%)
     
  • Russell 2000 Futures

    1,998.80
    -2.90 (-0.14%)
     
  • Crude Oil

    90.75
    +0.25 (+0.28%)
     
  • Gold

    1,772.00
    +0.80 (+0.05%)
     
  • Silver

    19.43
    -0.03 (-0.17%)
     
  • EUR/USD

    1.0092
    0.0000 (-0.00%)
     
  • 10-Yr Bond

    2.8800
    -0.0130 (-0.45%)
     
  • Vix

    19.56
    -0.34 (-1.71%)
     
  • GBP/USD

    1.1932
    -0.0000 (-0.00%)
     
  • USD/JPY

    135.9270
    +0.0650 (+0.05%)
     
  • BTC-USD

    23,213.31
    -127.72 (-0.55%)
     
  • CMC Crypto 200

    551.93
    -5.80 (-1.04%)
     
  • FTSE 100

    7,541.85
    +26.10 (+0.35%)
     
  • Nikkei 225

    28,942.14
    0.00 (0.00%)
     

Utah Medical Products (NASDAQ:UTMD) Is Paying Out A Dividend Of $0.29

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

The board of Utah Medical Products, Inc. (NASDAQ:UTMD) has announced that it will pay a dividend on the 5th of October, with investors receiving $0.29 per share. This payment means the dividend yield will be 1.3%, which is below the average for the industry.

See our latest analysis for Utah Medical Products

Utah Medical Products' Earnings Easily Cover The Distributions

Even a low dividend yield can be attractive if it is sustained for years on end. Before making this announcement, Utah Medical Products was easily earning enough to cover the dividend. As a result, a large proportion of what it earned was being reinvested back into the business.

Looking forward, earnings per share could rise by 4.6% over the next year if the trend from the last few years continues. If the dividend continues along recent trends, we estimate the payout ratio will be 61%, which is in the range that makes us comfortable with the sustainability of the dividend.

historic-dividend
historic-dividend

Utah Medical Products Has A Solid Track Record

Even over a long history of paying dividends, the company's distributions have been remarkably stable. The annual payment during the last 10 years was $0.96 in 2012, and the most recent fiscal year payment was $1.16. This means that it has been growing its distributions at 1.9% per annum over that time. Although we can't deny that the dividend has been remarkably stable in the past, the growth has been pretty muted.

Utah Medical Products May Find It Hard To Grow The Dividend

Investors who have held shares in the company for the past few years will be happy with the dividend income they have received. However, Utah Medical Products has only grown its earnings per share at 4.6% per annum over the past five years. While EPS growth is quite low, Utah Medical Products has the option to increase the payout ratio to return more cash to shareholders.

We Really Like Utah Medical Products' Dividend

Overall, we like to see the dividend staying consistent, and we think Utah Medical Products might even raise payments in the future. The company is easily earning enough to cover its dividend payments and it is great to see that these earnings are being translated into cash flow. All of these factors considered, we think this has solid potential as a dividend stock.

It's important to note that companies having a consistent dividend policy will generate greater investor confidence than those having an erratic one. At the same time, there are other factors our readers should be conscious of before pouring capital into a stock. For example, we've picked out 1 warning sign for Utah Medical Products that investors should know about before committing capital to this stock. If you are a dividend investor, you might also want to look at our curated list of high yield dividend stocks.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here